Cart
sales@molnova.com
CRANAD-28
CAS No. 1623747-97-6
CRANAD-28( CRANAD 28 | CRANAD28 )
Catalog No. M23719 CAS No. 1623747-97-6
CRANAD-28 can mark plaques and cerebral amyloid angiopathy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 270 | In Stock |
|
| 10MG | 386 | In Stock |
|
| 25MG | 626 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | 1224 | In Stock |
|
| 500MG | 2448 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCRANAD-28
-
NoteResearch use only, not for human use.
-
Brief DescriptionCRANAD-28 can mark plaques and cerebral amyloid angiopathy.
-
DescriptionCRANAD-28 can mark plaques and cerebral amyloid angiopathy. It is a blood-brain barrier (BBB) penetrating two-photon imaging probe.
-
In Vitro——
-
In Vivo——
-
SynonymsCRANAD 28 | CRANAD28
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1623747-97-6
-
Formula Weight484.3
-
Molecular FormulaC27H23BF2N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (10.32 mM)
-
SMILES[F-][B+3]1(O=C(/C=C/C2=C(N(N=C2)C3=CC=CC=C3)C)[CH-]C(/C=C/C4=C(N(N=C4)C5=CC=CC=C5)C)=O1)[F-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang X, Tian Y, Yuan P, Li Y, Yaseen MA, Grutzendler J, Moore A, Ran C. A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer's disease. Chem Commun (Camb). 2014 Oct 9;50(78):11550-3. doi: 10.1039/c4cc03731f. PubMed PMID: 25134928; PubMed Central PMCID: PMC4617557.
molnova catalog
related products
-
(1R)-(-)-Menthyl ace...
(1R)-(-)-Menthyl acetate is a derivative of L-menthol.
-
C5 Lenalidomide
C5 Lenalidomide is an chemical weith inconclusive biological activity.
-
GAC0003A4
GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.
